Angela Harmon
Family · Warsaw, KYNPI 1619440070
Payments from drug & device makers
Across 174 payments — averaging $16.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$298
- Corcept Therapeutics$252
- Novo Nordisk$169
- Lilly USA, LLC$161
- AstraZeneca$157
- plus $603 from 14 others
What the payments were for
- Food & beverage$2,796100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 79 | $1,156 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 19 | $298 |
| Corcept Therapeutics | 16 | $252 |
| Novo Nordisk | 9 | $169 |
| Lilly USA, LLC | 11 | $161 |
| AstraZeneca | 6 | $157 |
| Bayer | 5 | $100 |
| Amgen | 5 | $78 |
| Otsuka America Pharmaceutical, Inc. | 4 | $76 |
| Medtronic | 4 | $75 |
| Biohaven Pharmaceuticals, Inc. | 4 | $48 |
| Exact Sciences | 2 | $42 |
| GSK | 2 | $32 |
| Lundbeck LLC | 1 | $30 |
| Axsome Therapeutics, Inc. | 1 | $30 |
| Astellas Pharma US Inc | 2 | $29 |
| Viatris Specialty LLC | 1 | $22 |
| E.r. Squibb & Sons, L.L.C. | 1 | $16 |
| Boehringer Ingelheim | 1 | $15 |
| Dexcom, Inc. | 1 | $12 |
How this compares
$2,796 in reported general payments places this provider in the 85th percentile of 4,374 family providers in Kentucky.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| FarxigaDapagliflozin Propanediol | 49 | $58,419 |
| OzempicSemaglutide | 53 | $56,875 |
| MounjaroTirzepatide | 49 | $56,044 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 60 | $42,438 |
| JardianceEmpagliflozin | 25 | $38,110 |
| TrulicityDulaglutide | 17 | $27,815 |
| EliquisApixaban | 19 | $22,341 |
| EntrestoSacubitril/Valsartan | 12 | $19,654 |
| Repatha SureclickEvolocumab | 22 | $13,088 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 20 | $12,611 |
| Breo ElliptaFluticasone/Vilanterol | 24 | $11,406 |
| MyrbetriqMirabegron | 17 | $11,249 |
| Praluent PenAlirocumab | 11 | $7,399 |
| Spiriva RespimatTiotropium Bromide | 11 | $5,755 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 92 | $3,973 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro, Trulicity | $161 | $83,85966 claims |
| AstraZenecaFarxiga, Breztri Aerosphere | $157 | $71,03069 claims |
| Novo NordiskOzempic | $169 | $56,87553 claims |
| GSKTrelegy Ellipta, Breo Ellipta | $32 | $53,84484 claims |
| Boehringer IngelheimJardiance, Spiriva Respimat | $15 | $43,86536 claims |
| Astellas Pharma US IncMyrbetriq | $29 | $11,24917 claims |
| AbbVieArmour Thyroid | $1,156 | $99513 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 4,374 family providers in Kentucky.
Other family in Warsaw
- Bonnie HillLouisa$372K
- Ashley SnellenElizabethtown$190K
- Smita RanjanLouisville$92K
- Elizabeth SaltLexington$89K
- Tracey GaslinLouisville$79K
- Kassandra GreenLouisville$69K
- Danielle RevertLouisville$65K
- Lora BrownMonticellow$61K
- Shelley WaldmanLouisville$59K
- Vicki ChapmanMount Vernon$57K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.